SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001399529-20-000089
Filing Date
2020-11-05
Accepted
2020-11-05 16:20:39
Documents
72
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q drna-20200930.htm   iXBRL 10-Q 1716377
2 EX-10.1 drna20200930ex101.htm EX-10.1 77986
3 EX-10.2 drna20200930ex102.htm EX-10.2 76267
4 EX-10.3 drna20200930ex103.htm EX-10.3 40712
5 EX-10.4 drna20200930ex104.htm EX-10.4 42721
6 EX-31.1 drna20200930ex311.htm EX-31.1 7895
7 EX-31.2 drna20200930ex312.htm EX-31.2 7872
8 EX-32.1 drna20200930ex321.htm EX-32.1 6915
14 drna-20200930_g1.jpg GRAPHIC 395796
  Complete submission text file 0001399529-20-000089.txt   7565563

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20200930.xsd EX-101.SCH 48101
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20200930_cal.xml EX-101.CAL 68910
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20200930_def.xml EX-101.DEF 211460
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20200930_lab.xml EX-101.LAB 465332
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20200930_pre.xml EX-101.PRE 330705
15 EXTRACTED XBRL INSTANCE DOCUMENT drna-20200930_htm.xml XML 1010675
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 201290763
SIC: 2834 Pharmaceutical Preparations